Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 8 | BMC Cancer

Fig. 8

From: Copper’s new role in cancer: how cuproptosis-related genes could revolutionize glioma treatment

Fig. 8

MP-HJ-1b Reduces SLC31A1 Expression and Suppresses Proliferation, Invasion, and Migration Abilities of LN229 Cells. (A) Significant reduction in SLC31A1 protein expression in LN229 cells after treatment with MP-HJ-1b. (B) Immunofluorescence Validation of the effect of MP-HJ-1b on SLC31A1 Protein Expression. The results demonstrate that both LN229 cell group and over-expression cell group exhibit decreased expression of SLC31A1 protein after treatment with MP-HJ-1b. Each bar represents the mean ± SEM of three independent experiments. Compared to over-expression, #### p < 0.0001; compared to Con, *p < 0.05. (C) Transwell assay demonstrates the inhibitory effect of MP-HJ-1b on the invasion ability of LN229 cells. (D) Scratch assay indicates a notable decrease in the migration ability of cells treated with MP-HJ-1b. (E) Colony formation assay shows that MP-HJ-1b significantly inhibits the colony formation ability of LN229 cells. Each bar represents the mean ± SEM of three independent experiments. Compared to the over-expression, the over-expression-MP-HJ-1b group exhibits significant statistical differences, ##p < 0.01, ### p < 0.001, #### p < 0.0001; compared to the LN229 group, the LN229-MP-HJ-1b group show significant statistical differences, *p < 0.05, **p < 0.01

Back to article page